EU approves GelrinC (Regentis Biomaterials) for Cartilage Repair
Regentis Biomaterials has received European CE Mark approval for its GelrinC biodegradable implant, for Cartilage Repair. GelrinC is suitable for patients with traumatic knee injuries. It is inserted as a liquid to fill any shape of cartilage defect and it is then converted into a solid through exposure to ultra-violet light. GelrinC's matrix of synthetic polyethylene glycol diacrylate and denatured fibrinogen creates an environment conducive to cartilage tissue regeneration.
After GelrinC is implanted, it starts to bio-degrade as it is replaced with new hyaline-like cartilage. Regentis conducted a clinical trial treating 23 patients with damaged articular cartilage. The results were extremely positive with patients' knees effectively returning to normal, pain-free function.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins